Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Aug;36(8):1785–1787. doi: 10.1128/aac.36.8.1785

In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis.

B A Perkins 1, R J Hamill 1, D M Musher 1, C O'Hara 1
PMCID: PMC192049  PMID: 1416867

Abstract

We tested in vitro the activities of streptomycin and tetracycline--antibiotics that have long been used to treat rhinoscleroma--as well as several newer oral agents by using 23 isolates of the causative organism Klebsiella rhinoscleromatis. All isolates were inhibited by clinically achievable concentrations of trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, chloramphenicol, ciprofloxacin, cephalexin, cefuroxime, and cefpodoxime.

Full text

PDF
1785

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann G., Ostfeld E., Zohar S., Theodor E. Rhinoscleroma. Isr J Med Sci. 1977 Jan;13(1):62–64. [PubMed] [Google Scholar]
  2. Berger S. A., Pollock A. A., Richmond A. S. Isolation of Klebsiella ozaenae and Klebsiella rhinoscleromatis in a general hospital. Am J Clin Pathol. 1977 May;67(5):499–502. doi: 10.1093/ajcp/67.5.499. [DOI] [PubMed] [Google Scholar]
  3. Cone L. A., Barton S. M., Woodard D. R. Treatment of scleroma with ceforanide. Arch Otolaryngol Head Neck Surg. 1987 Apr;113(4):374–376. doi: 10.1001/archotol.1987.01860040036012. [DOI] [PubMed] [Google Scholar]
  4. DARRELL J. H., HURDLE A. D. IDENTIFICATION AND CLINICAL SIGNIFICANCE OF KLEBSIELLA SPECIES IN CHEST INFECTIONS. J Clin Pathol. 1964 Nov;17:617–621. doi: 10.1136/jcp.17.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Darouiche R., Perkins B., Musher D., Hamill R., Tsai S. Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis. 1990 Nov;162(5):1124–1127. doi: 10.1093/infdis/162.5.1124. [DOI] [PubMed] [Google Scholar]
  6. EPSTEIN S. S. The biochemistry and an tribiotic sensitivity of the Klebsiellae. J Clin Pathol. 1959 Jan;12(1):52–58. doi: 10.1136/jcp.12.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gamea A. M. Local rifampicin in treatment of rhinoscleroma. J Laryngol Otol. 1988 Apr;102(4):319–321. doi: 10.1017/s0022215100104840. [DOI] [PubMed] [Google Scholar]
  8. Gamea A. M., el-Tatawi F. A. The effect of rifampicin on rhinoscleroma: an electron microscopic study. J Laryngol Otol. 1990 Oct;104(10):772–777. doi: 10.1017/s002221510011388x. [DOI] [PubMed] [Google Scholar]
  9. Lenis A., Ruff T., Diaz J. A., Ghandour E. G. Rhinoscleroma. South Med J. 1988 Dec;81(12):1580–1582. doi: 10.1097/00007611-198812000-00029. [DOI] [PubMed] [Google Scholar]
  10. Miller R. H., Shulman J. B., Canalis R. F., Ward P. H. Klebsiella rhinoscleromatis: a clinical and pathogenic enigma. Otolaryngol Head Neck Surg (1979) 1979 Mar-Apr;87(2):212–221. doi: 10.1177/019459987908700211. [DOI] [PubMed] [Google Scholar]
  11. Muzyka M. M., Gubina K. M. Problems of the epidemiology of scleroma. I. Geographical distribution of scleroma. J Hyg Epidemiol Microbiol Immunol. 1971;15(3):233–242. [PubMed] [Google Scholar]
  12. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. QUEVEDO J. Scleroma in Guatemala, with a study of the disease based on the experience of 108 cases. Ann Otol Rhinol Laryngol. 1949 Sep;58(3):613-45, illust. doi: 10.1177/000348944905800301. [DOI] [PubMed] [Google Scholar]
  14. Shum T. K., Whitaker C. W., Meyer P. R. Clinical update on rhinoscleroma. Laryngoscope. 1982 Oct;92(10 Pt 1):1149–1153. [PubMed] [Google Scholar]
  15. Ssali C. L. The management of rhinoscleroma. J Laryngol Otol. 1975 Jan;89(1):91–99. doi: 10.1017/s0022215100080117. [DOI] [PubMed] [Google Scholar]
  16. van den Broek P. J. Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis. 1989 Mar-Apr;11(2):213–245. doi: 10.1093/clinids/11.2.213. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES